General Discussions

Nurse Answers: Is Your Job Depressing?

People often ask oncology nurses, "Isn't your job depressing?" Angee Kilmer, BSN, RN-BC, nursing supervisor of radiation oncology for the University of Kansas Cancer Centers and contr...

Michael Kelley on Distribution of Precision Medicine

This is the good though to spread the medicines across many other places to all patients. As per kibin survey this will definitely help in curing the particular illness and increase the stamina in ...

What Would You Do: Should Topical Anesthetics be Used to Numb the Skin Overlying an Implanted Port Prior to Noncoring Needle Insertion?

Interventions to reduce the pain of port access should be considered, especially in patients who have a low pain threshold. Several types of anesthetics are available including topical, injectable...

Advanced NSCLC: Expert Talks Recent Advancements, Shortcomings

The treatment of patients with advanced non-small cell lung cancer (NSCLC) has drastically changed within recent years, thanks to the advent of targeted therapy and immunotherapy. Chemotherapy also...

Reducing Transfusion Burden in Patients With Beta-Thalassemia

A majority of adult patients with β-thalassemia who require regular red blood cell (RBC) transfusions experienced clinically meaningful and durable transfusion burden reduction associated with...

Expert Discusses Olaparib for BRCA+ Pancreatic Cancer

In December 2019, the Food and Drug Administration (FDA) approved olaparib (Lynparza) for the frontline maintenance treatment of patients with BRCA-positive pancreatic cancer. This was a major ad...

Nurse Offers Advice on Discussing AEs With Patients

Kathleen Madden, MSN, RN, APHN, AOCNP, FNP-BC, a nurse practitioner at NYU Langone Health's Perlmutter Cancer Center, offers nurses and other providers advice on detecting and discussing adve...

FDA Grants Priority Review to Belantamab Mafodotin for Relapsed/Refractory Myeloma

The FDA granted a priority review to belantamab mafodotin for the treatment of heavily pre-treated patients with relapsed or refractory multiple myeloma, according to GlaxoSmithKline.1 With this, ...

External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.